UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

TD Cowen reaffirmed a “Buy” rating on AutoZone, Inc. (NYSE:AZO) with a price target of $4,300. TD Cowen analyst, Max Rakhlenko, emphasized that the company is performing well despite some short-term ...

A common over-the-counter drug used by millions to relieve UTI symptoms is now under serious scrutiny. Phenazopyridine — sold under brand names like Azo and Pyridium — has been linked to cancer in ...

This revision follows the company’s FQ3 2025 report, which saw AutoZone deliver a domestic comparable sales beat but ...

Chief Financial Officer Jackson reported inflation was "roughly flat" year-over-year, with about 1% this quarter. Forward ...

Truist Securities on Tuesday expressed confidence in AutoZone, Inc. (NYSE: AZO )’s trajectory by lifting the stock’s price ...

We feel like we have our arms around [tariffs], even though it’s changing every day,” said AutoZone CEO Phil Daniele.

AutoZone remains a top long-term holding, compounding value through consistent growth, international expansion, and an ...

AutoZone missed Q3 earnings estimates on weaker margins despite solid sales growth, but remains optimistic heading into the ...

AutoZone Inc on Tuesday reported a 6.6% drop in quarterly profit, as softening demand and currency fluctuations weighed on ...

Comparable sales were up 3.2% during the quarter to beat the consensus estimate for a rise of 1.8%. Domestic comparable sales ...

MEMPHIS, Tenn. (AP) — MEMPHIS, Tenn. (AP) — AutoZone Inc. (AZO) on Tuesday reported fiscal third-quarter earnings of $608.4 million. The Memphis, Tennessee-based company said it had net income of ...